Piramal plans to buy ailing biotechs; Pfizer nixes hopes for sweetened Icagen bid; Aura BioSciences raises about $3M;

@FierceBiotech: Study: Less than 1% of cancer patients enrolled in a clinical trial. Piece Very troubling. | Follow @FierceBiotech

@JohnCFierce: 52% of hospital/pharmacy purchasing agents bought drugs from gray market vendors in past 2 years. Price gouging? Article | Follow @JohnCFierce

@RyanMFierce: I have to think Medtronic folks are scrambling in the wake of the storm created by the insulin-pump hacker's report Story $MDT | Follow @RyanMFierce

@MaureenFierce: FDA issues dire warning after personal massage device kills a patient. Report | Follow @MaureenFierce

> Indian drug developer Piramal says it plans to spend up to $1.5 billion buying ailing mid-sized biotechs in the U.S. and Europe. Story

> Pfizer says it simply isn't interested in paying any more than $6 a share to acquire Icagen, even if its bid doesn't succeed in spurring shareholders to tender more than half of the shares. A number of investors have balked at the offer, saying the bid undervalues the biotech. Report

> The nanotech drug delivery company Aura Biosciences has raised nearly $3 million in a new round. Story

> Germany's AiCuris says the FDA has granted fast track status to its HCMV drug letermovir (AIC246). AiCuris release

> Tekmira Pharmaceuticals has acquired an exclusive worldwide license to RNAi technology from Halo-Bio. Tekmira release

Pharma News

 @FiercePharma: Piramal sold off its generics biz to Abbott. Now, founder wants to grow overseas via $1.5B in deals. Item $ABT | Follow @FiercePharma

> Pfizer/BMS clot drug expected to best Pradaxa, Xarelto. Article

Biotech IT News

> Alzheimer's trial database finds takers in W. Florida. More

> NexDocs opens the door to VC with $10.3M funding. Report

> Case Western spinoff wins NIH grant for software. News

> China a new frontier for growing clinical tech firm. Article

> Report: Samsung to test genetic analysis service. Details

> NIH pumping $25M to link EMR info to genetic data. Story

Medical Device News

> Abbott Molecular, Pfizer get nod for drug, companion Dx. Details

> Yates to head EMD Millipore. News

> Medtronic sees positive results with CoreValve. Article

And Finally... A new study finds that there's a lot of truth in the old saying about laughter being the best medicine. Researchers say laughing helps the body's vascular system, just as mental stress can damage it. Release

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.